Cargando…
A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy
A 53-year-old male Japanese patient with COVID-19 was admitted to our hospital after his respiratory condition worsened on day 9 of the disease. With the diagnosis of severe COVID-19, treatment with remdesivir, dexamethasone, and unfractionated heparin was started for the prevention of thrombosis. A...
Autores principales: | Sasaki, Kosaku, Murata, Masayuki, Nakamura, Keiji, Matsumoto, Yuji, Nakashima, Yuko, Yamasaki, Sho, Ota, Azusa, Hiramine, Satoshi, Takayama, Koji, Ikezaki, Hiroaki, Toyoda, Kazuhiro, Ogawa, Eiichi, Shimono, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091339/ https://www.ncbi.nlm.nih.gov/pubmed/35570112 http://dx.doi.org/10.1016/j.jiac.2022.05.001 |
Ejemplares similares
-
Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in Japan
por: Ikezaki, Hiroaki, et al.
Publicado: (2021) -
Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011) -
Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019) -
Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia
por: Nilius, Henning, et al.
Publicado: (2021) -
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)